NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Epigenomic profiling reveals DNA-methylation changes associated with major psychosis.

Author(s): Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L, Jia P, Assadzadeh A, Flanagan J, Schumacher A, Wang SC, Petronis A

Publication: Am J Hum Genet, 2008, Vol. 82, Page 696-711

PubMed ID: 18319075 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine if DNA methylation patterns in brain regions vary as a result of patient gender, postmortem interval, or disease state.

Conclusion of Paper

DNA methylation state was not correlated to postmortem interval, brain weight, or brain pH. The extent of CpG island methylation of an area approximately 30 kb upstream of the mitogen-activated protein kinase kinase I (MEK1) gene was significant correlated and inversely proportional to prolonged use of anti-psychotic drugs in biospecimens procured from both male and females diagnosed with schizophrenia but not bipolar disorder. Several sex-specific methylation patterns were also observed.

Studies

  1. Study Purpose

    The purpose of this study was to determine if DNA methylation patterns in brain regions vary as a result of patient gender, postmortem interval, or disease state.

    Summary of Findings:

    DNA methylation state was not correlated to postmortem interval, brain weight, or brain pH. The extent of CpG island methylation of an area approximately 30 kb upstream of the mitogen-activated protein kinase kinase I (MEK1) gene was significant correlated and inversely proportional to prolonged use of anti-psychotic drugs in biospecimens procured from both male and females diagnosed with schizophrenia but not bipolar disorder. Several sex-specific methylation patterns were also observed.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Bipolar Disorder
    • Schizophrenia
    Platform:
    AnalyteTechnology Platform
    DNA DNA microarray
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Patient gender Female
    Male
    Biospecimen Acquisition Organ measurements Brain weight 1314-1486 g
    Preaquisition Diagnosis/ patient condition Bipolar disorder
    Schizophrenia
    Preaquisition Other drugs Prolonged use of antipsychotic medication (varying doses)

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...